LENZNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
LENZ Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$3.30+0.03 (+0.92%)
Close on Oct 19, 2026
- Market cap
- $103.54M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of LENZ Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 11, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 11, 2026 | Aug 11, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 30, 2026 | Jul 2, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 12, 2026 | Jun 12, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 11, 2026 | SEC EDGAR |
| Current report | 8-K | May 11, 2026 | May 11, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 12, 2026 | Apr 28, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 24, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 24, 2026 | Mar 24, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 7, 2026 | Jan 7, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 12, 2025 | Dec 12, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 5, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 5, 2025 | Nov 5, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 8, 2025 | Oct 8, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 30, 2025 | Sep 30, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 31, 2025 | Jul 31, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Jul 30, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 30, 2025 | Jul 30, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 10, 2025 | Jun 10, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 7, 2025 | SEC EDGAR |
| Current report | 8-K | May 7, 2025 | May 7, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 10, 2025 | Apr 28, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 15, 2025 | Apr 15, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 4, 2025 | Apr 4, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 19, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 19, 2025 | Mar 19, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 6, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 6, 2024 | Nov 6, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 27, 2024 | Oct 28, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 14, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 14, 2024 | Aug 14, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2024 | Aug 12, 2024 | SEC EDGAR |
| Current report | 8-K | Jul 14, 2024 | Jul 15, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 8, 2024 | SEC EDGAR |
| Current report | 8-K | May 8, 2024 | May 8, 2024 | SEC EDGAR |
| Current report | 8-K | Apr 3, 2024 | Apr 3, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 21, 2024 | Mar 22, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 19, 2024 | Mar 19, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 14, 2024 | Mar 14, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 8, 2024 | Mar 8, 2024 | SEC EDGAR |